Jeani Delagardelle - Net Worth and Insider Trading

Jeani Delagardelle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeani Delagardelle owns 8 companies in total, including iRhythm Technologies Inc (IRTC) , MEI Pharma Inc (MEIP) , and Aravive Inc (ARAV) among others .

Click here to see the complete history of Jeani Delagardelle’s form 4 insider trades.

Insider Ownership Summary of Jeani Delagardelle

Ticker	Comapny	Transaction Date	Type of Owner
IRTC	iRhythm Technologies Inc	2016-10-19	10 percent owner
MEIP	MEI Pharma Inc	2012-12-18	10 percent owner
ARAV	Aravive Inc	2014-03-20	10 percent owner
		2013-04-10	10 percent owner
		2014-02-12	10 percent owner
		2013-11-27	other: Former 10% Beneficial Owner
		2013-11-20	other: Former 10% beneficial owner
		2011-07-13	10 percent owner

Jeani Delagardelle Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeani Delagardelle Ownership Network

Ownership Network List of Jeani Delagardelle

No Data

Ownership Network Relation of Jeani Delagardelle

Jeani Delagardelle Owned Company Details

What does iRhythm Technologies Inc do?

Who are the key executives at iRhythm Technologies Inc?

Jeani Delagardelle is the 10 percent owner of iRhythm Technologies Inc. Other key executives at iRhythm Technologies Inc include Chief Financial Officer Brice Bobzien , EVP Strategic Business Ops Mervin Smith , and Chief Commercial Officer Chad Patterson .

iRhythm Technologies Inc (IRTC) Insider Trades Summary

Over the past 18 months, Jeani Delagardelle made no insider transaction in iRhythm Technologies Inc (IRTC). Other recent insider transactions involving iRhythm Technologies Inc (IRTC) include a net sale of 16,421 shares made by Daniel G. Wilson , a net sale of 10,826 shares made by Patrick Michael Murphy , and a net sale of 4,628 shares made by Chad Patterson .

In summary, during the past 3 months, insiders sold 6,476 shares of iRhythm Technologies Inc (IRTC) in total and bought 0 shares, with a net sale of 6,476 shares. During the past 18 months, 68,847 shares of iRhythm Technologies Inc (IRTC) were sold and 10,035 shares were bought by its insiders, resulting in a net sale of 58,812 shares.

iRhythm Technologies Inc (IRTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

iRhythm Technologies Inc Insider Transactions

No Available Data

What does MEI Pharma Inc do?

Who are the key executives at MEI Pharma Inc?

Jeani Delagardelle is the 10 percent owner of MEI Pharma Inc. Other key executives at MEI Pharma Inc include Chief Medical Officer Richard G Ghalie , 10 percent owner Amin Nathoo , and 10 percent owner Funicular Funds, Lp .

MEI Pharma Inc (MEIP) Insider Trades Summary

Over the past 18 months, Jeani Delagardelle made no insider transaction in MEI Pharma Inc (MEIP). Other recent insider transactions involving MEI Pharma Inc (MEIP) include a net purchase of 201,660 shares made by Anson Funds Management Lp , and a net purchase of 134,440 shares made by Funicular Funds, Lp .

In summary, during the past 3 months, insiders sold 0 shares of MEI Pharma Inc (MEIP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MEI Pharma Inc (MEIP) were sold and 336,100 shares were bought by its insiders, resulting in a net purchase of 336,100 shares.

MEI Pharma Inc (MEIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

MEI Pharma Inc Insider Transactions

No Available Data

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

Jeani Delagardelle is the 10 percent owner of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc (ARAV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aravive Inc Insider Transactions

No Available Data

What does Chimerix Inc do?

Who are the key executives at Chimerix Inc?

Jeani Delagardelle is the 10 percent owner of Chimerix Inc. Other key executives at Chimerix Inc include Chief Business Officer Michael T. Andriole , Principal Accounting Officer David Jakeman , and director & Chief Executive Officer Michael A. Sherman .

Chimerix Inc (CMRX) Insider Trades Summary

Over the past 18 months, Jeani Delagardelle made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 60,000 shares made by Fred A Middleton , a net sale of 6,270 shares made by David Jakeman , and a net sale of 3,029 shares made by Michael T. Andriole .

In summary, during the past 3 months, insiders sold 1,285 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 1,285 shares. During the past 18 months, 11,239 shares of Chimerix Inc (CMRX) were sold and 173,750 shares were bought by its insiders, resulting in a net purchase of 162,511 shares.

Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chimerix Inc Insider Transactions

No Available Data

What does Concert Pharmaceuticals Inc do?

Who are the key executives at Concert Pharmaceuticals Inc?

Jeani Delagardelle is the 10 percent owner of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .

Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Concert Pharmaceuticals Inc Insider Transactions

No Available Data

What does Oxford Immunotec Global PLC do?

Who are the key executives at Oxford Immunotec Global PLC?

Jeani Delagardelle is the other: Former 10% Beneficial Owner of Oxford Immunotec Global PLC. Other key executives at Oxford Immunotec Global PLC include director & Chief Executive Officer Peter Wrighton-smith , Chief Financial Officer Mclaughlin Matthew T E , and Chief Operating Officer Stefan C Linn .

Oxford Immunotec Global PLC (OXFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oxford Immunotec Global PLC (OXFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oxford Immunotec Global PLC (OXFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oxford Immunotec Global PLC (OXFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oxford Immunotec Global PLC Insider Transactions

No Available Data

What does Relypsa Inc do?

Who are the key executives at Relypsa Inc?

Jeani Delagardelle is the other: Former 10% beneficial owner of Relypsa Inc. Other key executives at Relypsa Inc include SVP & Chief Commercial Officer J. Scott Garland , SVP & Chief Technology Officer Wilhelm Stahl , and See Remarks Ronald A. Krasnow .

Relypsa Inc (RLYP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Relypsa Inc (RLYP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relypsa Inc (RLYP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Relypsa Inc (RLYP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Relypsa Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Jeani Delagardelle is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Jeani Delagardelle made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net purchase of 788,500 shares made by James D Dondero , a net sale of 48,967 shares made by Evan Loh , and a net sale of 34,526 shares made by William M. Haskel .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 646,154 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

Jeani Delagardelle Mailing Address

Above is the net worth, insider trading, and ownership report for Jeani Delagardelle. You might contact Jeani Delagardelle via mailing address: C/o New Leaf Venture Partners, L.l.c., 2500 Sand Hill Road, Suite 203, Menlo Park Ca 94025.

Discussions on Jeani Delagardelle

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.